In gastric cancer, NRP1 also acts as a receptor for major signaling pathways including vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and semaphorin-3A (SEMA3), showing an important role in tumor development and metastasis [9,10]. Here, NRP1 is linked to neoplasm.